| Verona Pharma Is Launching Ohtuvayre, Although There Will Be Competition | 06/30 09:00 | seekingalpha.com |
| First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product | 06/27 09:49 | benzinga.com |
| Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month | 06/27 09:03 | reuters.com |
| US FDA approves Verona Pharma's therapy for 'smoker's lungs' | 06/26 17:13 | reuters.com |
| Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine) | 06/26 16:57 | globenewswire.com |
| Verona Pharma plc (VRNA) Q1 2024 Earnings Call Transcript | 05/09 12:31 | seekingalpha.com |
| Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update | 05/09 07:15 | globenewswire.com |
| Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS | 05/09 07:00 | globenewswire.com |
| Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024 | 05/02 02:00 | globenewswire.com |
| Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update | 04/25 02:00 | globenewswire.com |